Viewing Study NCT00191178



Ignite Creation Date: 2024-05-05 @ 11:58 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00191178
Status: COMPLETED
Last Update Posted: 2010-10-13
First Post: 2005-09-12

Brief Title: Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Study Overview

Official Title: Pilot Study Investigating the Effects of Insulin Lispro Low Mixture Therapy Compared With Insulin Glargine on Perceived Mood Symptoms in Patients With Type 2 Diabetes Mellitus
Status: COMPLETED
Status Verified Date: 2010-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study investigates the influence of two different insulin regimens twice-daily insulin lispro low mix LM and once-daily insulin glargine on perceived physical mood and cognitive symptoms as well as cognitive-motor task performance in patients with type 2 diabetes
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
F3Z-MC-IOOC None None None